Stem cells and kidney regeneration

Journal of the Formosan Medical Association

Volumn 113, Issue 4, 2014, Pages 201-209

  Chou, Yu Hsiang ^a,b   Pan, Szu Yu ^a   Yang, Chian Huei ^b   Lin, Shuei Liong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bioengineered kidney; Endothelial progenitor cell; Kidney regeneration; Renal progenitor cell; Stem cell

Indexed keywords

ANGIOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; EMBRYONIC STEM CELL; END STAGE RENAL DISEASE; ENDOTHELIUM CELL; FIBROBLAST; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; KIDNEY DEVELOPMENT; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY REGENERATION; KIDNEY TUBULE CELL; MACROPHAGE; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; ANIMAL; CYTOLOGY; KIDNEY; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; WNT SIGNALING PATHWAY;

PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMALS; HUMANS; KIDNEY; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; REGENERATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; WNT SIGNALING PATHWAY;

EID: 84897113361     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2013.12.001     Document Type: Review

References (96)

1. Chiu Y.L., Chien K.L., Lin S.L., Chen Y.M., Tsai T.J., Wu K.D. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 2008, 109:c109-c118.
2. Yang H.Y., Wang J.D., Lo T.C., Chen P.C. Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists. J Formos Med Assoc 2011, 110:161-168.
3. Lin Wu F.L., Chen Y.M., Lai T.S., Shen L.J., Ho Y.F., Lee Y.T., et al. Does Chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan?. Nephron Clin Pract 2012, 120:c215-c222.
4. Lai C.F., Tsai H.B., Hsu S.H., Chiang C.K., Huang J.W., Huang S.J. Withdrawal from long-term hemodialysis in patients with end-stage renal disease in Taiwan. J Formos Med Assoc 2013, 112:589-599.
5. Huang Y.Y., Lin K.D., Jiang Y.D., Chang C.H., Chung C.H., Chuang L.M., et al. Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009. J Formos Med Assoc 2012, 111:637-644.
6. Department of Health: National Health Insurance Annual Statistical Report 2011, Department of Health, Taiwan, ROC.
7. Lin S.L., Chen Y.M., Chiang W.C., Wu K.D., Tsai T.J. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: A 12-month randomized trial. Am J Kidney Dis 2008, 52:464-474.
8. Chang F.C., Chou Y.H., Chen Y.T., Lin S.L. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. J Formos Med Assoc 2012, 111:589-598.
9. Chou Y.H., Huang T.M., Wu V.C., Wang C.Y., Shiao C.C., Lai C.F., et al. Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care 2011, 15:R134.
10. Wu V.C., Huang T.M., Lai C.F., Shiao C.C., Lin Y.F., Chu T.S., et al. Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int 2011, 80:1222-1230.
11. Chou Y.H., Chen Y.F., Lin S.L. More is not better: fluid therapy in critically ill patients with acute kidney injury. J Formos Med Assoc 2013, 112:112-114.
12. Gomez I.G., Grafals M., Portilla D., Duffield J.S. MicroRNAs as potential therapeutic targets in kidney disease. J Formos Med Assoc 2013, 112:237-243.
13. Yeh P.Y., Liao F.L., Lin S.L. Is the renoprotective effect of erythropoietin in chronic kidney disease a myth?. J Formos Med Assoc 2013, 112:655-656.
14. Haller H., de Groot K., Bahlmann F., Elger M., Fliser D. Stem cells and progenitor cells in renal disease. Kidney Int 2005, 68:1932-1936.
15. Hopkins C., Li J., Rae F., Little M.H. Stem cell options for kidney disease. J Pathol 2009, 217:265-281.
16. Benigni A., Morigi M., Remuzzi G. Kidney regeneration. Lancet 2010, 375:1310-1317.
17. Long D.A., Norman J.T., Fine L.G. Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 2012, 8:244-250.
18. Humphreys B.D., Valerius M.T., Kobayashi A., Mugford J.W., Soeung S., Duffield J.S., et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008, 2:284-291.
19. Martin P., Parkhurst S.M. Parallels between tissue repair and embryo morphogenesis. Development 2004, 131:3021-3034.
20. Monte J.C., Sakurai H., Bush K.T., Nigam S.K. The developmental nephrome: systems biology in the developing kidney. Curr Opin Nephrol Hypertens 2007, 16:3-9.
21. Witzgall R., Brown D., Schwarz C., Bonventre J.V. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994, 93:2175-2188.
22. Imgrund M., Gröne E., Gröne H.J., Kretzler M., Holzman L., Schlöndorff D., et al. Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1. Kidney Int 1999, 56:1423-1431.
23. Hendry C.E., Little M.H. Reprogramming the kidney: a novel approach for regeneration. Kidney Int 2012, 82:138-146.
24. Lin S.L., Li B., Rao S., Yeo E.J., Hudson T.E., Nowlin B.T., et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA 2010, 107:4194-4199.
25. Lee S., Huen S., Nishio H., Nishio S., Lee H.K., Choi B.S., et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011, 22:317-326.
26. Lin S.L., Duffield J.S. Macrophages in kidney injury and repair. Acta Nephrol 2012, 26:45-57.
27. Gobe G.C., Johnson D.W. Distal tubular epithelial cells of the kidney: potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 2007, 39:1551-1561.
28. Zhuang J., Deane J.A., Yang R.B., Li J., Ricardo S.D. SCUBE1, a novel developmental gene involved in renal regeneration and repair. Nephrol Dial Transplant 2010, 25:1421-1428.
29. Schrimpf C., Xin C., Campanholle G., Gill S.E., Stallcup W., Lin S.L., et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 2012, 23:868-883.
30. Lin S.L., Kisseleva T., Brenner D.A., Duffield J.S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008, 173:1617-1627.
31. Ponnusamy M., Ma L., Zhuang S. Necrotic renal epithelial cell inhibits renal interstitial fibroblast activation: role of protein tyrosine phosphatase 1B. Am J Physiol Renal Physiol 2013, 304:F698-F709.
32. Gurdon J.B., Melton D.A. Nuclear reprogramming in cells. Science 2008, 322:1811-1815.
33. Iwasaki H., Akashi K. Hematopoietic developmental pathways: on cellular basis. Oncogene 2007, 26:6687-6696.
34. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
35. Song B., Niclis J.C., Alikhan M.A., Sakkal S., Sylvain A., Kerr P.G., et al. Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol 2011, 22:1213-1220.
36. Zhou T., Benda C., Dunzinger S., Huang Y., Ho J.C., Yang J., et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 2012, 7:2080-2089.
37. Wagers A.J., Weissman I.L. Plasticity of adult stem cells. Cell 2004, 116:639-648.
38. Poulsom R., Forbes S.J., Hodivala-Dilke K., Ryan E., Wyles S., Navaratnarasah S., et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001, 195:229-235.
39. Lin F., Moran A., Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005, 115:1756-1764.
40. Duffield J.S., Park K.M., Hsiao L.L., Kelley V.R., Scadden D.T., Ichimura T., et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005, 115:1743-1755.
41. Rookmaaker M.B., Smits A.M., Tolboom H., Van't Wout K., Martens A.C., Goldschmeding R., et al. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol 2003, 163:553-562.
42. Li B., Morioka T., Uchiyama M., Oite T. Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int 2006, 69:323-330.
43. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981, 78:7634-7638.
44. Chen Y.T., Sun C.K., Lin Y.C., Chang L.T., Chen Y.L., Tsai T.H., et al. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 2011, 9:51.
45. Donizetti-Oliveira C., Semedo P., Burgos-Silva M., Cenedeze M.A., Malheiros D.M., Reis M.A., et al. Adipose tissue-derived stem cell treatment prevents renal disease progression. Cell Transplant 2012, 21:1727-1741.
46. Kobayashi T., Tanaka H., Kuwana H., Inoshita S., Teraoka H., Sasaki S., et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun 2005, 336:585-595.
47. Steenhard B.M., Isom K.S., Cazcarro P., Dunmore J.H., Godwin A.R., St John P.L., et al. Integration of embryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol 2005, 16:1623-1631.
48. Kim D., Dressler G.R. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 2005, 16:3527-3534.
49. Yamamoto M., Cui L., Johkura K., Asanuma K., Okouchi Y., Ogiwara N., et al. Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells. Am J Physiol Renal Physiol 2006, 290:F52-F60.
50. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008, 321:699-702.
51. Bussolati B., Bruno S., Grange C., Buttiglieri S., Deregibus M.C., Cantino D., et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005, 166:545-555.
52. Okita K., Nagata N., Yamanaka S. Immunogenicity of induced pluripotent stem cells. Circ Res 2011, 109:720-721.
53. Little M.H. Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 2006, 17:2390-2401.
54. Herzlinger D., Koseki C., Mikawa T., al-Awqati Q. Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction. Development 1992, 114:565-572.
55. Yamashita S., Maeshima A., Nojima Y. Involvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys. J Am Soc Nephrol 2005, 16:2044-2051.
56. Hartman H.A., Lai H.L., Patterson L.T. Cessation of renal morphogenesis in mice. Dev Biol 2007, 310:379-387.
57. Lee P.T., Lin H.H., Jiang S.T., Lu P.J., Chou K.J., Fang H.C., et al. Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. Stem Cells 2010, 28:573-584.
58. Weissman I.L., Anderson D.J., Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 2001, 17:387-403.
59. Coskun V., Wu H., Blanchi B., Tsao S., Kim K., Zhao J., et al. CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci USA 2008, 105:1026-1031.
60. Ivanova L., Hiatt M.J., Yoder M.C., Tarantal A.F., Matsell D.G. Ontogeny of CD24 in the human kidney. Kidney Int 2010, 77:1123-1131.
61. Romagnani P., Lasagni L., Remuzzi G. Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol 2013, 9:137-146.
62. Ronconi E., Sagrinati C., Angelotti M.L., Lazzeri E., Mazzinghi B., Ballerini L., et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009, 20:322-332.
63. Angelotti M.L., Ronconi E., Ballerini L., Peired A., Mazzinghi B., Sagrinati C., et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012, 30:1714-1725.
64. Bruno S., Bussolati B., Grange C., Collino F., di Cantogno L.V., Herrera M.B., et al. Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev 2009, 18:867-880.
65. Pleniceanu O., Harari-Steinberg O., Dekel B. Concise review: kidney stem/progenitor cells: differentiate, sort out, or reprogram?. Stem Cells 2010, 28:1649-1660.
66. Nigam eS., Lieberthal W. Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Renal Physiol 2000, 279:F3-F11.
67. Lieberthal W., Fuhro R., Andry C.C., Rennke H., Abernathy V.E., Koh J.S., et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001, 281:F693-F706.
68. Fresno Vara J.A., Casado E., de Castro J., Cejas P., Belda-Iniesta C., González-Barón M. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 2004, 30:193-204.
69. Chen J., Chen J.K., Harris R.C. Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney Int 2012, 82:45-52.
70. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998, 74:49-139.
71. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001, 81:807-869.
72. di Mari J.F., Davis R., Safirstein R.L. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 1999, 277:F195-F203.
73. Arany I., Megyesi J.K., Nelkin B.D., Safirstein R.L. STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney Int 2006, 70:669-674.
74. Ishizuka S., Yano T., Hagiwara K., Sone M., Nihei H., Ozasa H., et al. Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury. Biochem Biophys Res Commun 1999, 254:88-92.
75. Salahudeen A.K., Haider N., Jenkins J., Joshi M., Patel H., Huang H., et al. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2008, 294:F1354-F1365.
76. Ucero A.C., Berzal S., Ocana-Salceda C., Sancho M., Orzaez M., Messeguer A., et al. A polymeric nanomedicine diminishes inflammatory events in renal tubular cells. PloS One 2013, 8:e51992.
77. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009, 10:468-477.
78. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001, 65:391-426.
79. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003, 116:1175-1186.
80. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004, 29:95-102.
81. Wang Z., Havasi A., Gall J., Bonegio R., Li Z., Mao H., et al. GSK3beta promotes apoptosis after renal ischemic injury. J Am Soc Nephrol 2010, 21:284-294.
82. Zhou D., Li Y., Lin L., Zhou L., Igarashi P., Liu Y. Tubule-specific ablation of endogenous beta-catenin aggravates acute kidney injury in mice. Kidney Int 2012, 82:537-547.
83. Bao H., Ge Y., Zhuang S., Dworkin L.D., Liu Z., Gong R. Inhibition of glycogen synthase kinase-3beta prevents NSAID-induced acute kidney injury. Kidney Int 2012, 81:662-673.
84. Fine L.G., Orphanides C., Norman J.T. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int 1998, 65:S74-S78.
85. Lin S.L., Chang F.C., Schrimpf C., Chen Y.T., Wu C.F., Wu V.C., et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 2011, 178:911-923.
86. Maeshima Y., Makino H. Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair 2010, 3:13.
87. Chang F.C., Lin S.L. The role of angiopoietin-2 in progressive renal fibrosis. J Formos Med Assoc 2013, 112:175-176.
88. Kang D.H., Hughes J., Mazzali M., Schreiner G.F., Johnson R.J. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001, 12:1448-1457.
89. Lee S., Kim W., Moon S.O., Sung M.J., Kim D.H., Kang K.P., et al. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant 2007, 22:396-408.
90. David S., John S.G., Jefferies H.J., Sigrist M.K., Kümpers P., Kielstein J.T., et al. Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 2012, 27:1867-1872.
91. Chang F.C., Lai T.S., Chiang C.K., Chen Y.M., Wu M.S., Chu T.S., et al. Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. PloS One 2013, 8:e54668.
92. Wu V.C., Young G.H., Huang P.H., Lo S.C., Wang K.C., Sun C.Y., et al. In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin. Angiogenesis 2013, 16:609-624.
93. Yasuda K., Park H.C., Ratliff B., Addabbo F., Hatzopoulos A.K., Chander P., et al. Adriamycin nephropathy: a failure of endothelial progenitor cell-induced repair. Am J Pathol 2010, 176:1685-1695.
94. Humes H.D., Buffington D.A., MacKay S.M., Funke A.J., Weitzel W.F. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 1999, 17:451-455.
95. Humes H.D., Weitzel W.F., Bartlett R.H., Swaniker F.C., Paganini E.P., Luderer J.R., et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004, 66:1578-1588.
96. Song J.J., Guyette J.P., Gilpin S.E., Gonzalez G., Vacanti J.P., Ott H.C. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013, 19:646-651.